Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Use of prescription drugs in the older adult population-a nationwide pharmacoepidemiological study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Drug-drug interactions between vitamin K antagonists and statins: a systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males: the LIFESTAT study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Quality assessment of structure and language elements of written responses given by seven Scandinavian drug information centres

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

PURPOSE: Multi-morbidity and polypharmacy are common among older people. It is essential to provide a better understanding of the complexity of prescription drug use among older adults to optimise rational pharmacotherapy. Population-based utilisation data in this age group is limited. Using the Danish nationwide health registries, we aimed to characterise drug use among Danish individuals ≥ 60 years.

METHODS: This is a descriptive population-based study assessing drug prescription patterns in 2015 in the full Danish population aged ≥ 60 years. The use of specific therapeutic subgroups and chemical subgroups and its dependence on age were described using descriptive statistics. Profiles of drug combination patterns were evaluated using latent class analysis.

RESULTS: We included 1,424,775 residents (median age 70 years, 53% women). Of all the older adults, 89% filled at least one prescription during 2015. The median number of drug groups used was five per person. The most used single drug groups were paracetamol and analogues (34%), statins (33%) and platelet aggregation inhibitors (24%). Eighteen drug profiles with different drug combination patterns were identified. One drug profile with expected use of zero drugs and 11 drug profiles expected to receive more than five different therapeutic subgroup drugs were identified.

CONCLUSION: The use of drugs is extensive both at the population level and increasing with age at an individual level. Separating the population into different homogenous groups related to drug use resulted in 18 different drug profiles, of which 11 drug profiles received on average more than five different therapeutic subgroup drugs.

TidsskriftEuropean Journal of Clinical Pharmacology
Udgave nummer8
Sider (fra-til)1125-1133
Antal sider9
StatusUdgivet - aug. 2019

ID: 56946707